|
US6465016B2
|
|
Cyclosporiine particles
|
|
AU3404900A
|
|
Compositions comprising microparticles of water-insoluble substances
|
|
IL137734D0
|
|
Method and composition for treatment of inflammatory conditions
|
|
PL331715A1
|
|
Composition containing microparticles of water-insoluble substances and method of obtaining such compositions
|
|
AU7461796A
|
|
Insoluble drug delivery
|
|
AU6400796A
|
|
Novel adjuvant compositions and vaccine formulations comprising same
|
|
US5660858A
|
|
Cyclosporin emulsions
|
|
US5637625A
|
|
Propofol microdroplet formulations
|
|
US5785975A
|
|
Adjuvant compositions and vaccine formulations comprising same
|
|
US5885956A
|
|
Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand
|
|
AU2175692A
|
|
Use of vasoactive intestinal peptide (VIP) to induce temporary paralysis of the gastrointestinal tract
|
